AM20-66: Ask the FDA

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Emily Storch, MD, FDA/CBER/OBRR
• Kanaeko Ravenell, FDA
• Sharon O'Callaghan, MT(ASCP), FDA/CBER
• Kip J. Hanks, FDA Office of Regulatory Affairs, Office of Biological Products Operations
• Lisa Harlan, FDA Office of Regulatory Affairs, Office of Biological Products Operations

Tags: quality donor testing collections and product manufacturing patient safety red cells immunohematology includes serology public health and policy standards regulations and accreditation collections processing and storage molecular diagnostics and testing

AM20-69: Benefit-Risk Assessment to Inform FDA Regulatory Decisions

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Hong Yang, PhD, FDA/CBER
• Dr. Richard Forshee, PhD, FDA/CBER
• Dr. Yin Huang, Food and Drug Administration

Tags: public health and policy standards regulations and accreditation recipientpatient hemovigilance - transfusion transmitted infec

AM20-82: Firearm Injuries in the United States: National Data and Evolution of the Transfusion Management Evidence Base

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. John R. Hess, MD, Division of Transfusion Medicine, University of Washington
• Dr. Eric A. Gehrie, MD, Medical Director of the Blood Bank, Johns Hopkins University School of Medicine
• Dr. Ruchika Goel, M.D., MPH, Johns Hopkins University School of Medicine

Tags: donor hemovigilance noninfectious adverse events hematopoietic cell therapytransplant evidence based medical practices transfusion medicine clinical practices donor apheresis public health and policy pediatric transfusion clinical medicine trauma and massive transfusion practices

AM20-89: Malaria Susceptibility and Erythrocyte Antigens: An Update in the Genomic Age

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Christine Cserti-Gazdewich, University Health Network
• Dr. Elizabeth Egan, MD, PHD, Stanford University School of Medicine
• Dr. Jensyn Cone Sullivan, MD, Brigham and Women's Hospital

Tags: new innovations new techniques and new technologies red cells immunohematology includes serology public health and policy molecular diagnostics and testing immunohematology and genetic testing red cells leukocytes and

AM20-49: Updates from the 2019 National Blood Collection and Utilization Survey (NBCUS) and Beyond

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Jefferson M. Jones, MD, MPH, Centers for Disease Control and Prevention
• John E. Murphy, OneBlood, Inc.
• Nina Salamon, Gardens Office Park

Tags: donor collections collections and product manufacturing strategic planning public health and policy operations inventory management component processing laboratory administration blood bankblood center donor collection testing processing

AM20-45: Automated Hemovigilance: Fast Healthcare Interoperability Resources (FHIR) and Big Data Analysis

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Hamilton C. Tsang, MD, University of Washington
• Dr. Alan Williams, PhD, US FDA, Center for Biologics Evaluation and Research
• Dr. Aaron Z. Hettinger, MD, MedStar Health Research Institute

Tags: new innovations new techniques and new technologies public health and policy recipientpatient hemovigilance - noninfectious adverse events information technology it aka informatics ehr lis recipientpatient hemovigilance - transfusion transmitted infec

AM20-42: Rh Disease: Still a Global Problem

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Hua Shan, MD, PhD, Stanford University
• Dr. Sarah Vossoughi, MD, Columbia University Irving Medical Center
• Dr. Krystalyn E. Hudson, Ph.D, Assistant Professor, Department of Pathology and Cell Biology, Columbia University Medical Center

Tags: new innovations new techniques and new technologies evidence based medical practices transfusion medicine clinical practices immunohematology includes serology public health and policy pediatric transfusion clinical medicine

AM20-33: COVID-19 Convalescent Plasma (CCP) -- The Regulatory Landscape

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, FDA
• Dr. Nicole Verdun, MD, Director, Office of Blood Research and Review, FDA

Tags: public health and policy standards regulations and accreditation donor hemovigilance transfusion transmitted diseases

AM20-32: Late-breaking Oral Abstract Session

Oct 4, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Mars Stone, PhD, Vitalant Research Institute
• Dr. Bryan R. Spencer, PhD, American Red Cross Scientific Affairs
• Dr. Sonia Bakkour, PhD, Vitalant Research Institute
• Dr. Erin G. Meyer, DO, MPH, American Red Cross
• Dr. Richard Gammon, MD, Medical Director, OneBlood, SMT Medical Direction

Tags: donor collections transfusion medicine clinical practices public health and policy donor recruitment and retention

AM20-25: A Step Above the Basics of HLA for Apheresis/Transfusion Practitioners

Oct 4, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Patricia Kopko, MD, Professor of Pathology, Director of Transfusion Medicine, Associate Director, Immunogenetics and Transplantation Laboratory, Associate Director, Pathology Residency Training Program, University of California San Diego
• Harold Sullivan, Emory University School of Medicine
• Dr. Deanna C. Fang, M.D., David Geffen School of Medicine at UCLA

Tags: hematopoietic cell therapytransplant evidence based medical practices transfusion medicine clinical practices strategic planning public health and policy patient testing therapeutic apheresis